Kenneth Atz
Kenneth Atz
1ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093 Zurich, Switzerland
1,
Leandro Cotos
Leandro Cotos
1ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093 Zurich, Switzerland
1,
Clemens Isert
Clemens Isert
1ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093 Zurich, Switzerland
1,
Maria Håkansson
Maria Håkansson
2SARomics Biostructures AB, Medicon Village, SE-223 81 Lund, Sweden
2,
Dorota Focht
Dorota Focht
2SARomics Biostructures AB, Medicon Village, SE-223 81 Lund, Sweden
2,
Mattis Hilleke
Mattis Hilleke
1ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093 Zurich, Switzerland
1,
David F Nippa
David F Nippa
3Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland
4Department of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstrasse 5, 81377 Munich, Germany
3,4,
Michael Iff
Michael Iff
1ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093 Zurich, Switzerland
1,
Jann Ledergerber
Jann Ledergerber
1ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093 Zurich, Switzerland
1,
Carl C G Schiebroek
Carl C G Schiebroek
1ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093 Zurich, Switzerland
1,
Valentina Romeo
Valentina Romeo
3Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland
3,
Jan A Hiss
Jan A Hiss
1ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093 Zurich, Switzerland
1,
Daniel Merk
Daniel Merk
4Department of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstrasse 5, 81377 Munich, Germany
4,
Petra Schneider
Petra Schneider
1ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093 Zurich, Switzerland
1,
Bernd Kuhn
Bernd Kuhn
3Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland
3,
Uwe Grether
Uwe Grether
3Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland
3,
Gisbert Schneider
Gisbert Schneider
1ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093 Zurich, Switzerland
1,✉
1ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, 8093 Zurich, Switzerland
2SARomics Biostructures AB, Medicon Village, SE-223 81 Lund, Sweden
3Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland
4Department of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstrasse 5, 81377 Munich, Germany
Subject terms: Structure-based drug design, Machine learning, Computational chemistry, Medicinal chemistry
© The Author(s) 2025
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.